Score history

NuuVive Peptides score history

Every recorded change to NuuVive Peptides’s overall score since October 14, 2026, with the audit note written at the time. Scores follow our published methodology; affiliate status never affects them.

FairRead the full NuuVive Peptides review

Score today: 6.93/10
Score today
Score changes: 12
Score changes
Audit entries: 13
Audit entries

Score over time

Overall score, October 14, 2026 to November 6, 2026. Each dot is a recorded score; the filled dot is today’s.

Every entry newest first

November 5, 2026Raised from6.91to6.93(+0.02)
Pricing re-checked on 5 November 2026 after the market medians were recalculated pricing 4.5 to 4.6.
November 2, 2026Lowered from6.94to6.91(-0.03)
Market medians updated after Pacific Edge Labs was added pricing 4.7 to 4.5.
October 27, 2026Lowered from6.96to6.94(-0.02)
Market medians updated after S1Research was added pricing 4.8 to 4.7.
October 27, 2026Raised from6.94to6.96(+0.02)
Pricing recomputed on 27 October 2026: listings added for a newly reviewed vendor (Peptide Pro) moved the market median for the same products pricing 4.7 to 4.8.
October 27, 2026Lowered from6.96to6.94(-0.02)
Pricing recomputed on 27 October 2026: listings added for a newly reviewed vendor (NovaForge Labs) moved the market median for the same products: pricing 4.8 to 4.7.
October 26, 2026Lowered from6.97to6.96(-0.01)
Pricing recomputed on 26 October 2026: listings added for a newly reviewed vendor (Lotus Peptide) moved the market median for the same products: pricing 4.9 to 4.8.
October 25, 2026Lowered from6.99to6.97(-0.02)
Pricing recomputed on 25 October 2026: listings added for a newly reviewed vendor (Pexo Labs) moved the market median for the same products: pricing 5.0 to 4.9.
October 24, 2026Raised from6.97to6.99(+0.02)
Pricing recomputed on 24 October 2026: listings added for newly reviewed vendors moved the market median for the same products: pricing 4.9 to 5.0.
October 23, 2026Lowered from6.99to6.97(-0.02)
Pricing recomputed on 23 October 2026 from current listings with the published rule (section E), after listings added or updated since 22 October, including a newly reviewed vendor's, moved the market median for the same products: pricing 5.0 to 4.9.
October 22, 2026Lowered from7.13to6.99(-0.14)
Re-scored on 22 October 2026 under our published rubric for shipping, pricing, operating history and transparency, applied to every vendor the same day: prices re-read from the vendor's site and matched by milligrams per vial, operating history from the earliest dated evidence of the business, and policies scored item by item. pricing 5.5 to 5.0, operating history 2.5 to 1.7, transparency 7.0 to 6.5.
October 22, 2026Raised from6.41to7.13(+0.72)
Janoshik certificates confirmed on 22 October 2026 at the laboratory's own verification site, so each confirmed report now earns the key-confirmed credit under our published lab rule. Lab 6.2 to 7.5.
October 22, 2026Lowered from6.58to6.41(-0.17)
Lab score recalculated on 22 October 2026 under the uniform published rubric applied to every vendor: every listed product was rescored on the same fixed certificate points, with fixed deductions for certificates ordered by a supplier or issued to another business. Lab 6.5 to 6.2.
October 14, 2026First publishedat6.58
lab 6.5 / shipping 8.5 / pricing 5.5 / tenure 2.5 / transparency 7.0.

Score changes for every vendor are on the score changes page. NuuVive Peptides may display its current score with the score badge, which updates automatically and has no effect on the score.